Who is sponsoring NCT03491592?

NCT03491592 is sponsored by Brown University.

What drugs are being tested in NCT03491592?

Interventions in NCT03491592: Enhanced Physical Activity Intervention, Original Physical Activity Intervention.

What condition does NCT03491592 study?

NCT03491592 studies Inactivity.

Is NCT03491592 still recruiting?

NCT03491592 is currently completed. Last updated 22 February 2023.

Last reviewed 2023-02-22 · How we verify

NCT03491592

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Web-based Physical Activity Intervention for Latinas

Completed NA Last updated 22 February 2023

What this trial tests

NA trial testing Enhanced Physical Activity Intervention in Inactivity in 210 participants. Completed in 1 April 2022.

Timeline

1 June 2018

Primary endpoint
1 April 2022

1 April 2022

Quick facts

Lead sponsor	Brown University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	210
Start date	1 June 2018
Primary completion	1 April 2022
Estimated completion	1 April 2022
Sites	1 location across United States

Drugs / interventions tested

Enhanced Physical Activity Intervention
Original Physical Activity Intervention

Conditions studied

Inactivity — all drugs for Inactivity →

Sponsor

Brown University

Who can join

Adults 18 to 65, female only, with Inactivity. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This renewal builds upon our successful culturally adapted PA intervention for Latinas (Pasos Hacia La Salud, R01CA159954) and expands its focus to the critical area of maintenance of behavior change. This study will test an enhanced version of the original internet intervention in order to achieve greater increases in PA and longer term maintenance. Investigators propose to test this newly developed enhanced intervention (Enhanced Intervention) compared to the original Pasos Hacia La Salud Intervention (Original Intervention) in a 24-month randomized trial (N=300).

Publications & conference data

4 peer-reviewed publications reference this trial (live from Europe PMC):

Pasos Hacia La Salud II: A Superiority RCT Utilizing Technology to Promote Physical Activity in Latinas.
von Ash T, Dunsiger SI, Williams DM, Larsen BA, et al · · 2024 · cited 5× · PMID 38490284 · DOI 10.1016/j.amepre.2024.03.006
Pasos Hacia La Salud II: study protocol for a randomized controlled trial of a theory- and technology-enhanced physical activity intervention for Latina women, compared to the original intervention.
Mendoza-Vasconez AS, Benitez T, Dunsiger S, Gans KM, et al · · 2022 · cited 3× · PMID 35915473 · DOI 10.1186/s13063-022-06575-4
Six-Month Outcomes of a Theory- and Technology-Enhanced Physical Activity Intervention for Latina Women (Pasos Hacia La Salud II): Randomized Controlled Trial.
Connell Bohlen L, Dunsiger SI, von Ash T, Larsen BA, et al · · 2024 · cited 2× · PMID 38842930 · DOI 10.2196/51708
Costs and Cost-Effectiveness at 12 and 24 Months of an Enhanced Web-Based Physical Activity Intervention for Latina Adults: Secondary Analysis of a Randomized Controlled Trial.
Larsen B, Pekmezi D, Hartman SJ, Dunsiger S, et al · · 2025 · PMID 41289583 · DOI 10.2196/76739

Verify or expand the search:

Other recruiting trials for Inactivity

Currently open trials in the same condition.

NCT06623669 — A Mobile Intervention to Reduce Pain and Improve Health-III · Phase 2 · recruiting
NCT06848335 — Improving Physical Activity Participation in Latinas With Mindfulness · NA · recruiting
NCT07411248 — Exercise Approaches and Physical Activity Level in Inactive Adults · NA · recruiting

Other Brown University trials

Trials by the same sponsor.

NCT07502872 — TPG: Tafasitamab, Polatuzumab Vedotin, and Glofitamab as First-line Therapy for Diffuse Large B-cell Lymphoma and High-g · Phase 2 · not yet recruiting
NCT07118618 — Probenecid Administration for Alcohol Craving and Consumption · Phase 2 · recruiting
NCT07398443 — Using Novel Behavioral Economic Measures to Characterize Dual Marijuana and Tobacco Use in Young Adults · NA · recruiting
NCT05901766 — Effect of Iodine-containing Multiple Micronutrient During Lactation on Infant Neurodevelopment · Phase 4 · not yet recruiting
NCT06974604 — Preventing Dato-DXd Associated Stomatitis With Dexamethasone Mouthwash, TROPION-DM · Phase 2 · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03491592 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Brown University
Last refreshed: 22 February 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03491592.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing